Search for other papers by Shenghe Luo in
Google Scholar
PubMed
Department of Cardiology, Yanbian University Hospital, Yanji, China
Search for other papers by Yunhui Zuo in
Google Scholar
PubMed
Search for other papers by Xiaotian Cui in
Google Scholar
PubMed
Search for other papers by Meiping Zhang in
Google Scholar
PubMed
Search for other papers by Honghua Jin in
Google Scholar
PubMed
Search for other papers by Lan Hong in
Google Scholar
PubMed
Introduction Glucagon-like peptide 1 (GLP-1) is one of the components of incretin, which can regulate the metabolism of the body and has a wide range of pharmacological effects ( 1 , 2 ). GLP-1R agonists like as liraglutide are currently